Image

tDCS + CCFES-mediated Functional Task Practice for Post-stroke Upper Extremity Hemiplegia

tDCS + CCFES-mediated Functional Task Practice for Post-stroke Upper Extremity Hemiplegia

Recruiting
21-90 years
All
Phase N/A

Powered by AI

Overview

After a stroke, it is very common to lose the ability to open the affected hand. Occupational and physical rehabilitation therapy (OT and PT) combined with non-invasive brain stimulation may help a person recover hand movement.

The purpose of this study is to compare 3 non-invasive brain stimulation protocols combined with therapy to see if they result in different amounts of recovery of hand movement after a stroke.

Description

This study is a randomized clinical trail (RCT) of stroke survivors with chronic (6 to 24 months) hemiplegia randomized to: 1) conventional transcranial direct current stimulation (tDCS), 2) unconventional tDCS, or 3) sham tDCS during contralaterally controlled functional electrical stimulation mediated occupational therapy. The treatment will last 12 weeks and be followed by a 6-month follow-up period. Assessors, therapists and participants will be blinded to which tDCS treatment is received. This will be the first RCT of tDCS + CCFES.

Eligibility

Inclusion Criteria:

  1. Age ≥ 21 and ≤ 90
  2. ≥ 6 and ≤ 24 months since first clinical hemorrhagic or nonhemorrhagic stroke
  3. Able to follow 3-stage command
  4. Able to remember 2 of 3 items after 30 minutes
  5. Full volitional elbow extension/flexion and hand opening/closing of unaffected limb
  6. Adequate active movement of shoulder and elbow to position the paretic hand in the workspace for table-top task practice
  7. Patient must be able to sit unassisted in an armless straight-back chair for the duration of the screening portion of the eligibility assessment
  8. Medically stable
  9. ≥ 10° finger and wrist extension
  10. Skin intact on hemiparetic arm, hand and scalp
  11. Muscle contraction can be elicited with Transcranial Magnetic Stimulation
  12. Unilateral upper limb hemiparesis with finger extensor strength of ≤ grade 4/5 on the Medical Research Council (MRC) scale
  13. Score of ≥1/14 and ≤ 11/14 on the hand section of the upper extremity Fugl-Meyer Assessment
  14. While relaxed, surface NMES of finger extensors and thumb extensors and/or abductors produces a functional degree of hand opening without pain.

Exclusion Criteria:

  1. Co-existing neurological condition other than prior stroke involving the hemiparetic upper limb (e.g., peripheral nerve injury, PD, SCI, TBI, MS).
  2. Uncontrolled seizure disorder
  3. Use of seizure lowering threshold medications and the discretion of the study physician
  4. Cardiac pacemaker or other implanted electronic device
  5. Pregnant
  6. IM Botox injections in any UE muscle in the last 3 months
  7. Insensate arm, forearm, or hand
  8. Deficits in communication that interfere with reasonable study participation
  9. Severely impaired cognition and communication
  10. Uncompensated hemi-neglect (extinguishing to double simultaneous stimulation)
  11. Severe shoulder or hand pain (unable to position hand in the workspace without pain)

Study details
    Stroke
    Upper Extremity Paresis
    Hemiplegia

NCT05866003

MetroHealth Medical Center

25 January 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.